Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Nolato

61,15 SEK

-1,53 %

Mindre end 1K følgere

NOLA B

NASDAQ Stockholm

Industrial Goods & Services

Industrials

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
-1,53 %
+0,58 %
+2,51 %
+3,12 %
+12,82 %
+12,30 %
+9,78 %
-20,48 %
+5.057,86 %

Nolato operates in the manufacturing industry and focuses on the development, manufacture and distribution of plastic components and systems for various industries. The company's products are used in sectors such as the automotive industry, medical technology and consumer electronics. The business is global with a main presence in Europe, North America and Asia. Nolato was founded in 1938 and is headquartered in Torekov, Sweden.

Læs mere
Markedsværdi
16,47 mia. SEK
Aktieomsætning
5,76 mio. SEK
Omsætning
9,66 mia.
EBIT %
9,45 %
P/E
25,06
Udbytteafkast, %
2,45 %
Omsætning og EBIT-margin

Omsætning mia.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
5.2
2026

Årsrapport '25

6.5
2026

Generalforsamling '26

6.5
2026

Delårsrapport Q1'26

Alle
Selskabspræsentationer
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Eksterne analyser29.10.2025, 06.16

Nolato: No drama, just solid delivery - ABG

* More margin gains, 12% target now looking conservative* Adj. EBITA raised by 1-2% for '25e-'27e, mainly from Engineered* Trading at 14.5x '26e EV/EBITA vs. five-year average 15.3xMore margin gains, 12% target now looking conservativeNolato reported...

Nolato
Eksterne analyser28.10.2025, 14.44

Nolato: Slight beat on adj. EBITA - ABG

* Adj. EBITA SEK 274m (+4% vs. ABG, +2% vs. IR consensus)* We expect consensus adj. EBITA to come up by 1-2%* 14.5x '26e EV/EBITA on pre-Q3 estimates (and on yesterday's close)Q3 outcomeSales came in at SEK 2,342m (+1% vs. ABG 2,324m, 0% vs. IR cons ...

Nolato
Selskabsmeddelelse28.10.2025, 13.00

Sustained organic growth and strong margin increase

Nolato

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse21.10.2025, 07.45

Webcast conference call on 28 October about Nolato’s third quarter 2025

Nolato
Eksterne analyser14.10.2025, 07.09

Nolato: Margin expansion starting to plateau - ABG

* Q3e: Medical stable, but negative seasonality* EBITA estimates cut by 2-3%, mainly for Engineered* Share trading at 14x '26e EV/EBITAQ3e: stable Medical, but a seasonal drop in marginsWe expect Nolato will report Q3 net sales of SEK 2,324m, down 3%...

Nolato
Eksterne analyser20.7.2025, 19.22

Nolato: Margin train keeps going - ABG

Another impressive margin lift Nolato reported Q2 EBITA 5% and 7% above ABGSCe and IR consensus, respectively. The beat was broad-based, with better organic growth (2pp above ABGSCe), a better EBITA margin (0.4pp above ABGSCe, 0.6pp above cons), and ...

Nolato
Eksterne analyser18.7.2025, 06.51

Nolato - Better across the board - ABG

Q2 outcome Sales was SEK 2,395m (+2% vs. ABG 2,345m, +2% vs. IR cons 2,351m), down 2% y-o-y, although organic growth was +4% (ABG +2%). EBITA came in at SEK 277m (+5% vs ABG 264m, +7% vs. cons 259m), for an EBITA margin of 11.6% (ABG 11.2%, cons 11.0...

Nolato
Selskabsmeddelelse18.7.2025, 06.00

Organic growth with strong margin increase

Nolato
Eksterne analyser14.7.2025, 07.32

Nolato: We expect a repeat of strong margins - ABG

Q2e: FX headwinds, but continued strong margins We expect Nolato to report Q2 net sales of SEK 2,345m, a y-o-y decline of 4%, of which +2% is organic and -6% from FX, driven mainly by the weaker USD. Following its CMD on 13 March, when Nolato raised ...

Nolato
Pressemeddelelse11.7.2025, 09.00

Webcast conference call on 18 July about Nolato’s second quarter 2025

Nolato
Eksterne analyser7.5.2025, 05.12

Nolato: Impressive margin lift - ABG

Impressive margin lift in both segments, EBITA +6% vs. cons We raise EBITA by 4-1%, of which -1pp from FX 16-14x '25e-'26e EV/EBITA, 60% of EBITA non-cyclical Medical Impressive margin lift in both segments Nolato reported Q1 sales 2% below Modular Finance...

Nolato
Selskabsmeddelelse6.5.2025, 13.57

Press release from the Annual General Meeting in Nolato AB (publ) 6 May 2025

Nolato
Eksterne analyser6.5.2025, 12.40

Nolato: Bigger margin lift than expected - ABG

EBITA SEK 271m (+3% vs. ABG, +6% vs. IR cons) We expect cons EBITA upgrades of 3-4% for '25e 15-13x '25e-'26e EV/EBITA on pre-Q1 estimates Q1 outcome Sales came in at SEK 2,453m (-3% vs. ABG SEK 2,527m, -2% vs. Modular Finance IR cons SEK 2,494m), up...

Nolato
Selskabsmeddelelse6.5.2025, 11.00

Strengthened earnings and substantial margin increase

Nolato
Pressemeddelelse29.4.2025, 08.00

Webcast conference call on May 6 about Nolato’s interim report for Q1 2025

Nolato
Eksterne analyser15.4.2025, 08.04

Nolato: Resilient Medical exposure in a chaotic market - ABG

Q1e: a solid quarter with EBITA up 11% y-o-y Higher estimates following ambitious new targets Medical (~60% of EBITA) should be resilient in a downturn Q1e: a solid quarter with EBITA up 11% y-o-y We expect Nolato to report Q1 net sales of SEK 2,527m...

Nolato
Selskabsmeddelelse10.4.2025, 11.00

Nolato's Annual Report for 2024 published

Nolato
Selskabsmeddelelse2.4.2025, 08.00

Notice of Annual General Meeting 2025

Nolato
Eksterne analyser14.3.2025, 06.23

Nolato: CMD recap: back to earnings growth focus - ABG

>12% EBITA margin target looks doable... ...more uncertainty on the 8% org. growth target, in our view Back to earnings growth focus after a couple years of putting out fires >12% EBITA margin target looks doable... On its Capital Markets Day today, ...

Nolato
Nolato, Capital Markets Day, CMD, 2025
Videopræsentation13.3.2025, 12.00

Nolato, Capital Markets Day, CMD, 2025

Nolato
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.